efficacy 1
safety 1
antiil 1
p 1
monoclonal 1
antibody 1
ustekinumab 1
patients 1
active 1
psoriatic 1
arthritis 1
despite 1
conventional 1
nonbiological 1
biological 1
antitumour 1
necrosis 1
factor 1
therapy 1
month 1
results 1
phase 1
multicentre 1
doubleblind 1
placebocontrolled 1
randomised 1
psummit 1
trial 1
